GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Aetna Inc (NYSE:AET) » Definitions » Research & Development

Aetna (AET) Research & Development : $0 Mil (TTM As of Sep. 2018)


View and export this data going back to 1968. Start your Free Trial

What is Aetna Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Aetna's Research & Development for the three months ended in Sep. 2018 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2018 was $0 Mil.


Aetna Research & Development Historical Data

The historical data trend for Aetna's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aetna Research & Development Chart

Aetna Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aetna Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Aetna Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aetna  (NYSE:AET) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Aetna Research & Development Related Terms

Thank you for viewing the detailed overview of Aetna's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Aetna (AET) Business Description

Traded in Other Exchanges
N/A
Address
Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This large member count helps the firm diversify its operating risk and has formed the basis for material competitive advantages. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna and CVS recently announced their intention to merge operations, and if approved, it would form one of the most powerful players within the healthcare space.
Executives
Fernando Aguirre director CHIQUITA BRANDS INTERNATIONAL, 250 EAST FIFTH STREET, CINCINNATI OH 45202
Harold L Paz officer: EVP & Chief Medical Officer AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Molly Joel Coye director AETNA INC, 151 FARMINGTON AVENUE, HARTFORD CT 06156
Jeffrey E Garten director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Frank M Clark director AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Shawn M Guertin officer: Exec. Vice President, CFO TRINET GROUP, INC., ONE PARK PLACE, SUITE 600, DUBLIN CA 94568
Mark T Bertolini director, officer: Chairman and CEO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Karen S Lynch officer: President 151 FARMINGTON AVENUE, RW61, HARTFORD CT 06156
Roger N Farah director POLO RALPH LAUREN CORP, 650 MADISON AVE, NEW YORK NY 10022
Ellen M Hancock director 126 LIMESTONE ROAD, RIDGEFIELD CT 06877
Edward J Ludwig director C/O BECTON DICKERSON & CO, 1 BECTON DR, FRANKLIN LAKES NJ 07417
Margaret M Mccarthy officer: EVP, Operations & Technology AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Olympia J. Snowe director 100 E. PRATT STREET, BALTIMORE MD 21202
Heather Brianne Dixon officer: VP, Controller & CAO AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Sabatino Thomas J Jr officer: EVP & General Counsel C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015

Aetna (AET) Headlines

From GuruFocus

Huge Long Term Upside Still Available In Aetna Inc.

By Quantified Alpha Quantified Alpha 05-14-2015

Aetna the Undaunted Insurer

By Mark Yu Mark Yu 10-31-2016

5 Companies Reach 52-Week Highs

By yifan900 yifan900 11-29-2016

Aetna: Solid Prospects in a Volatile Environment

By Robert Abbott Robert Abbott 03-31-2015

Weekly 52-Week Highs Highlight: AET, BK, EQIX, MGA

By Jimmy Xiao gurujx 05-11-2015

Paul Tudor Jones Continues to Buy Apple, Alibaba

By Tiziano Frateschi Tiziano Frateschi 11-29-2018